SONOMA PHARMACEUTICALS, INC. Income (Loss) from Continuing Operations, Per Diluted Share
SONOMA PHARMACEUTICALS, INC. (SNOA) reported Income (Loss) from Continuing Operations, Per Diluted Share of -$0.31 per share for the 3-month period ending 2021-12-31, per its 10-Q filed 2022-02-11.
Discontinued › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2022-02-11
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2021-12-31 was -$0.31.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2021-09-30 was -$0.04, a 157.14% decline year-over-year.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2021-06-30 was -$0.52.
- SONOMA PHARMACEUTICALS, INC. income (loss) from continuing operations, per diluted share for the quarter ending 2020-12-31 was -$0.31.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.31 10-Q · filed 2022-02-11 | -$0.85 10-Q · filed 2022-02-11 | ||
| 2021-09-30 | -$0.04 10-Q · filed 2021-11-15 | -$0.54 10-Q · filed 2021-11-15 | ||
| 2021-06-30 | -$0.52 10-Q · filed 2021-08-16 | |||
| 2020-12-31 | -$0.31 10-Q · filed 2022-02-11 | -$0.60 10-Q · filed 2022-02-11 | ||
| 2020-09-30 | $0.07 10-Q · filed 2021-11-15 | -$0.26 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | -$0.38 10-Q · filed 2021-08-16 | $0.02 10-Q · filed 2020-08-14 | ||
| 2019-09-30 | -$0.98 10-Q · filed 2020-11-20 | -$0.47 10-Q · filed 2020-11-20 | ||
| 2019-06-30 | $0.51 10-Q/A · filed 2020-11-17 | $0.40 10-Q · filed 2020-08-14 | ||
| 2017-12-31 | -$0.73 10-Q · filed 2018-02-14 | -$2.21 10-Q · filed 2018-02-14 | ||
| 2016-12-31 | $0.18 10-Q · filed 2018-02-14 | -$1.36 10-Q · filed 2018-02-14 | ||
| 2015-12-31 | -$1.28 10-Q · filed 2017-02-17 | -$3.46 10-Q · filed 2017-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Co-Diagnostics, Inc. (CODX) | United States | $0.007B | -0.32 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |